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Background: The American Stroke Association/American Heart Association recommended the criteria for diagnosis
of vascular cognitive impairment and memory impairment (MI) is a feature in the classification of vascular mild
cognitive impairment (VaMCI). VaMCI patients with MI may differ in terms of infarct location or demographic features,
so we evaluated the clinical characteristics associated with MI in patients with VaMCI.
Methods: A prospective multicenter study enrolled 353 acute ischemic stroke patients who underwent evaluation
using the Korean Vascular Cognitive Impairment Harmonization Standard Neuropsychological Protocol at three
months after onset. The association between MI and demographic features, stroke risk factors, and infarct location
was assessed.
Results: VaMCI was diagnosed in 141 patients, and 58 (41.1%) exhibited MI. Proportions of men and of left side
infarcts were higher in VaMCI with MI than those without (75.9 vs. 57.8%, P = 0.03, 66.7 vs. 47%, P = 0.02). Multiple
logistic analyses revealed that male sex (odds ratio [OR] 3.07, 95% confidence interval [95% CI] 1.12-8.42), left-side
infarcts (OR 3.14, 95% CI 1.37-7.20), and basal ganglia/internal capsule infarcts (OR 4.53, 95% CI 1.55-13.22) were
associated with MI after adjusting other demographic variables, vascular risk factors, and subtypes of stroke.
Conclusions: MI is associated with sex and infarct location in VaMCI patients.Background
Vascular mild cognitive impairment (VaMCI) is a subtype
of vascular cognitive impairment (VCI) and commonly
follows stroke [1,2]. While VaMCI sometimes improves
with time, it is associated with an elevated risk of demen-
tia [3,4]. The American Stroke Association/American
Heart Association (ASA/AHA) recommended the follow-
ing criteria for VaMCI: patient exhibits impairment in at
least 1 of 4 cognitive domains (memory, executive/activa-
tion, visuospatial, language); display normal or mild im-
pairments in daily living activities; imaging results suggest
cerebrovascular disease; a temporal relationship exists be-
tween the stroke and the cognitive symptoms. Moreover,
it is recommended to apply these criteria in the study of
VaMCI after stroke [1,5].
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unless otherwise stated.several previous studies also indicated that clinical stroke
causes subsequent poorer performance in multiple cog-
nitive domains including memory [6-8]. Memory im-
pairment (MI) is a prerequisite for a diagnosis of vascular
dementia according to DSM-IV criteria and a feature in
the classification of VaMCI by ASA/AHA recommen-
dation [1,9]. Verbal memory declines over 3 years after
stroke [10] and impairment of verbal memory is associ-
ated with progression to dementia or vascular death
[4,11]. Memory domain has been considered as a key do-
main among all cognitive domains, however, little is known
about the clinical characteristics of VaMCI with MI.
The prevalence of MI is about 23–55% from a review
paper [12] and is 21.4–66.5% from previous studies about
VaMCI or VCI without dementia at 3–6 months after
stroke [4,6]. Hippocampal atrophy is generally not associ-
ated with VCI [13] and the correlation of MI with white
matter hyperintensities, infarct location or laterality were
reported after stroke, so the mechanisms of MI in VaMCIis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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studies showed some difference in age, gender, risk factors,
or hippocampal atrophy according to the subtypes of
VaMCI or VCI, but these differences were not evaluated
in the manner of multivariate analysis [4,14]. Thus, we
hypothesize that VaMCI patients with MI may differ in
terms of infarct location or demographic features after
adjusting the other demographic features, vascular risk
factors, and infarct subtypes or locations.
In addition, neuropsychological protocols previously
used to assess VCI have varied with respect to examined
cognitive domains [2,4,15]. VCI harmonization standards
(VCIHS) recommend the evaluation of four specified cog-
nitive domains to conform with ASA/AHA diagnostic
guidelines [16]. The Korean VCIHS neuropsychological
protocol (K-VCIHS-NP) assesses four cognitive domains
and has been validated for use in acute stroke patients
[17]. Therefore, the present study uses the K-VCIHS-NP
to investigate the associations between MI and the clinical
characteristics of VaMCI patients.consecutively admitted patients with ischemic 
stroke  (n=899)
Enrolled and underwent a baseline evaluation 
within two weeks of onset (n=620)
Vascular mild cognitive impairment (n=141)
Assessment with a 60-minutes K-VICHS-NP 3 
months after the onset (n=353)
Vascular cognitive impairment (n=221)
Follow-up post stroke assessment at 3 months 
(n=506)
Figure 1 Patient flow chart. K-VCIHS-NP, The Korean VCIHS neuropsych
Questionnaire of Cognitive Decline in the Elderly.Methods
Participants
Six hundred twenty acute ischemic stroke patients from
12 hospitals were enrolled in the study within 7 days of
symptom onset from October 2007 to August 2008. Ex-
clusion criteria and the exact number of patients for
each stage of the study are shown in Figure 1. A detailed
description of the methodology has been published else-
where [17]. Briefly, we conducted a baseline evaluation
within two weeks of stroke onset to determine demo-
graphic characteristics, vascular risk factors, stroke sub-
type [18], and functional status. Among these 620
patients, 353 completed the 60-min K-VCIHS-NP evalu-
ation at three months post-stroke.
Cognitive evaluation
The 60-min K-VCIHS-NP includes 7 tests that assess 4
cognitive domains: the Hopkins Verbal Learning Test for
memory; Semantic (animal) and phonemic fluency tests,
the Digit Symbol Coding, and the Trail Making Test forExcluded (n=279)
• severe medical or neurological condition such as 
aphasia (93)
• death within 2 weeks after stroke onset (8)
• referral to other hospital (16)
• refusal of informed consent (162)
Dropped before 3 months (n= 114)
• death after enrollment (19) lost to follow-up (95)
Normal cognition (n=132)
Vascular dementia (n=63), pre-stroke cognitive 
impairment (n=12) missing data in K-IQCODE  
(n=5)
Could not properly evaluated at 3 months (n= 153)
• unable to all cognitive tests (52) or some tests 
(10) due to neurological or medical condition
• withdrawal of consent (72)
• use of cognitive enhancers (19)
ological protocol; K-IQCODE, the Korean version of the Informant
Table 1 Comparison of baseline demographic features,
vascular risk factors, and location of cerebral infarcts
between vascular mild cognitive impairment patients
with and without memory impairment
Memory impairment P value
Present (n = 58) Absent (n = 83)
Age 64.2 ± 9.2 66.4 ± 12.2 0.09
Sex, men (%) 44 (75.9) 48 (57.8) 0.03
Previous stroke (%) 8 (13.8) 8 (9.6) 0.44
Hypertension (%) 35 (60.3) 55 (66.3) 0.47
Diabetes (%) 25 (43.1) 30 (36.1) 0.40
Hyperlipidemia (%) 15 (25.9) 12 (14.5) 0.09
Duration of education (yr) 4.9 ± 1.8 4.7 ± 1.6 0.34
NIH stroke scale score 3.9 ± 3.46 4.5 ± 4.85 0.99
Presense of left infarct (%) 38 (66.7)* 39 (47) 0.02
Location of infarcts
Cortex (%) 21 (36.2) 39 (47.0) 0.20
Corona radiata (%) 15 (25.9) 27 (32.5) 0.39
Basal ganglia/internal
capsule (%)
21 (36.2) 18 (21.7) 0.06
Thalamus (%) 9 (15.5) 6 (7.2) 0.12
Brainstem (%) 7 (12.1) 7 (8.4) 0.48
Cerebellum (%) 8 (13.8) 4 (4.8) 0.06
Multiple infarcts (%) 25 (43.1) 28 (52.8) 0.26
TOAST classification 0.36
Large artery disease 23 (39.7) 38 (45.8)
Small vessel occlusion 17 (29.3) 18 (21.7)
Cardioembolim 12 (20.7) 12 (14.5)
Other or undetermined 6 (10.3) 15 (18.1)
yr, year; NIH, National Institutes of Health; TOAST, Trial of Org 10172 in Acute
Stroke Treatment * one is missing in the information about stoke laterality, so
a total of 57 patients with MI was analyzed.
Cho et al. BMC Neurology  (2014) 14:244 Page 3 of 6executive function/activation; the Rey Complex Figure
Test-Copy for visuospatial skills; and the Boston Naming
Test for language [19].
We also administered the Korean version of the
Informant Questionnaire on Cognitive Decline in the
Elderly (K-IQCODE) to examine pre-morbid history of
cognitive impairment; the Instrumental Activities of
Daily Living scale (IADL) to assess instrumental com-
plex daily functioning; and the Korean version of the
Mini-Mental Status Examination (K-MMSE) and Clin-
ical Dementia Rating (CDR) as supplementary tests of
cognitive function at 3 months post-stroke. All tests
and scales were previously validated for the Korean lan-
guage and standardized in Korean subjects by age and
educational levels [20,21].
Diagnosis of VaMCI
The diagnostic procedure included a clinical interview
and the administration of the K-VCIHS-NP, K-IQCODE,
and IADL. Impaired cognitive function was defined as
impairment in at least one cognitive domain on the
K-VCIHS-NP, as indicated by a score below the 10th
percentile using normative corrections for an individual
domain. For executive function/activation domains, which
consisted of 4 tests, patients who scored below the 10th
percentile on more than 2 tests were identified as having
impaired functions. Abnormal functional status was indi-
cated by a score greater than 0.43 on the Korean IADL
[20]. Pre-stroke cognitive impairment was considered
present if the K-IQCODE score exceeded 3.6 [21]. A vas-
cular cause was presumed when cognitive impairment
emerged at 3 months after the stroke in the absence of
pre-stroke impairment. VaMCI was defined as impairment
in at least 1 of 4 cognitive domains, combined with nor-
mal or mild impairments in daily living activities and tem-
poral evidence of vascular causation [1].
Statistical analysis
We compared the demographic features and characteris-
tics of index infarcts of VaMCI patients based on the pres-
ence of MI, using a Mann-Whiteny test for continuous
variables and chi-square tests for categorical variables.
Univariate and multivariate logistic analyses examined the
influence of baseline demographic features, infarct loca-
tions, and classification of stroke subtypes on memory im-
pairment in VaMCI at 3-month after stroke. We entered
age, sex, duration of education, all locations and subtypes
of ischemic stroke in the logistic model for detailed de-
scription. Analyses were performed with SPSS (Windows
version 18.0).
Ethics statement
This study was approved by the Institutional Review
Board/Ethics Committee of each participating hospital(Hallym University Sacred Heart Hospital IRB 2007–137
http://hallym.hallym.or.kr/irb/). All subjects provided in-
formed consents. This study followed Good Clinical
Practice guidelines and was consistent with the Inter-
national Conference on Harmonization of ethical princi-
ples for medical research involving human subjects.
Results
At 3 months post stroke, 506 patients were follow-up and
353 patients completed K-VCI-HP. Cognitive impairments
were present in 221 patients, and VaMCI was diagnosed
in 141 patients (mean age: 65.5 ± 11.1 years, 92 men and
49 women; Figure 1). Causes of follow-up loss at 3 months
were death (n =19) and move away or transfer to another
hospitals (n = 95) and the causes of not completing K-
VCIHS-NP at 3 months are deteriorated neurological or
medical conditions (n =52), withdrawal of consent (n =
72), missing data of cognitive test (n = 10), and use of
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tients, MI was present in 58 patients (41.1%). Executive/
activation function was most commonly impaired (96,
68.1%), followed by visuospatial function (60, 42.6%), and
language function (38, 27%). MI was more frequent in
men than women (47.8% vs. 28.6%, P = 0.03), while no sex
differences were observed in the other domains.
Sixty-nine patients (48.9%) exhibited impairments in
two or more domains: There were 17 amnestic single
domain VaMCI patients, 41 amnestic multiple domain
VaMCI patients, 55 non-amnestic single domain VaMCI
patients, and 28 non-amnestic multiple domain VaMCI
patients. Combined memory and executive/activation
impairments were present in 35 patients, but these were
not correlated (r = 0.139, P = 0.10). Correlations were ob-
served between language and memory impairments (r =
0.888, P = 0.01) and language and visuospatial impair-
ments (r = 0.221, P = 0.009).
Baseline demographic features, vascular risk factors,
location, laterality, multiplicity, classification of index is-
chemic stroke are shown in Table 1. Proportions of men
and of left side infarcts were higher in VaMCI with MI
than those without (75.9 vs. 57.8%, P = 0.03, 66.7 vs.
47%, P = 0.02). VaMCI with MI tended to have a higher
chance of having basal ganglia/internal capsule (36.2
vs.21.7%, P = 0.06) or cerebellum (13.8 vs.4.8%, P = 0.06)





Education, year 1.07 (0.87-1.31)




Left infarct 2.26 (1.12-4.54)
TOAST classification
Large artery disease 0.78 (0.39-1.54)




Corona radiata 0.72 (0.34-1.53)




OR, odds ratio; 95% CI, 95% confidence interval; TOAST, Trial of Org 10172 in Acutetwo groups did not significantly differ in education
levels; the vascular risk factors; the other location or the
number of infarcts; TOAST classification (Table 1).
VaMCI with MI had a higher score in sum of box of
CDR (2.0 ± 1.9 vs.1.3 ± 1.3, P = 0.04) and showed a ten-
dency of lower score in K-MMSE (24.1 ± 5.3 vs. 25.7 ± 3.4,
P = 0.14) three months after stroke. There are no difference
in K-IQCODE (3.0 ± 0.53 vs. 3.0 ± 0.49) and instrumental
ADL (0.19 ± 0.37 vs. 0.19 ± 0.32) between two groups.
Logistic analyses with baseline demographic features,
vascular risk factors, and location and classification of
stroke revealed that male sex (odds ratio [OR] 3.07, 95%
confidence interval [95% CI] 1.12-8.42), left-side infarct
location (OR 3.14, 95% CI 1.37-7.20), and basal ganglia
or internal capsule infarct location (OR 4.53, 95% CI
1.55-13.22) were associated with MI (Table 2). Add-
itional logistic analyses with all above variables and K-
IQCODE showed similar results: Male sex (OR 3.48,
95% CI 1.21-10.02), left-side infarct location (OR 3.15,
95% CI 1.37-7.24), and basal ganglia or internal capsule
infarct location (OR 4.86, 95% CI 1.64-14.43) were asso-
ciated with MI, while no such association was observed
for other variables (data not shown).
Discussion
The present study showed that, after adjusting for age,
sex, stroke risk factors, education levels, and infarctmemory impairment
Multivariate
P value OR (95% CI) P value
0.25 0.98 (0.93-1.02) 0.27
0.03 3.07 (1.12-8.42) 0.03
0.53 0.83 (0.61.-1.12) 0.22
0.45 2.04 (0.55-7.57) 0.29
0.47 1.17 (0.46-2.93) 0.97
0.41 1.49(0.65-3.39) 0.34
0.09 1.93 (0.69-5.45) 0.21
0.02 3.14 (1.37-7.20) 0.007
0.47 0.90 (027–3.03) 0.86
0.30 2.12 (0.53-8.49) 0.29
0.34 2.20 (0.47-10.60) 0.32
0.20 0.97(0.32-2.91) 0.95
0.40 0.71 (0.26-1.92) 0.50
0.06 4.53 (1.55-13.22) 0.006
0.12 2.70 (0.71-10.22) 0.14
0.48 1.78 (0.37-8.57) 0.47
0.07 4.05 (0.81-20.14) 0.09
Stroke Treatment.
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male and have left side, basal ganglia, or internal capsule
infarcts. The follow-up rate with K-VCIHS-NP of pa-
tients in prospective acute stroke cohort was 69.8%
among 506 patients who were followed-up at 3 months
after stroke in this study (56.9% among baseline 620 pa-
tients) and the proportion of cognitive assessing was
somewhat low compared to the previous studies [15,22].
This discrepancy might be explained by the difference in
clinical setting as a multicenter setting and in study de-
sign excluding those with cognitive enhancer or in ex-
tensiveness of the neuropsychological protocol [17].
Sex differences in VaMCI have been indicated by sev-
eral studies [4,14,23]. For example, males are more likely
to have amnestic MCI [4,14], and females recover more
quickly from VaMCI [23]. While age-related cognitive
decline, vascular risk factors, and stroke are more com-
mon in men, it is unclear whether males are more sus-
ceptible to cognitive insult by vascular burden or aging
[24-26]. In addition, males were at subtle disadvantage
when performing this memory test in a previous paper;
thus, this should be considered during the rehabilitation
or cognitive testing of stroke patients [27].
Infarct location influenced the domain of cognitive im-
pairment. Basal ganglia and thalamic infarcts have been
associated with MI in previous studies [7,28-31]. The
basal ganglia is known to play a some role in the regula-
tion of memory and the association between MI and
basal ganglia infarcts is a line with the previous studies
[29,30,32]. MI was related to left-side infarcts and was
correlated with language impairment in this study.
While verbal memory tasks rely on intact language func-
tion, an association between left-side infarct and MI was
also found when memory was assessed using non-verbal
memory tests [10,33]. Thalamic infarcts were not related
to MI in this study. In a study with acute stroke patients,
associations between infrequent infarct location and cog-
nitive impairment may be difficult to detect if compari-
sons are not made with participants who have not
suffered a stroke.
The strength of this study is that it investigated the
clinical details of VaMCI with MI using ASA/AHA
guidelines for VaMCI diagnosis and VCIHS protocols
[1,16]. The exclusion of subjects with pre-stroke vascular
dementia or cognitive impairment does not guarantee
that the included participants did not have Alzheimer’s
disease or another form of dementia that contributed to
their MI. MI in VaMCI patients in this study may occur
from the current ischemic stroke or underlying degen-
erative disease, but the VaMCI with MI is worthy to
evaulate because of high risk of future dementia and
death [12,13].
This study has several limitations. First, we did not
measure white matter or infarct volume; or Alzheimer’sbiomarkers, such as hippocampal volume and apolipo-
protein E subtypes [13,14,34]. The study about MI in
VaMCI should be adjusted by these variables to confirm
the associations. Second, our results were not validated
by the long-term VaMCI outcome. Third, we only used
the Hopkins Verbal Learning Test to assess memory.
While the Hopkins Verbal Learning Test is the only
VCIHS-recommended memory test [35,36], adding vis-
ual memory or composite score of several memory tests
would be informative as an index of MI in stroke pa-
tients [30]. Fourth, the wide confidence interval of the
association between MI and stroke location may be re-
lated to the relatively small number of patients in each
location. The association between MI and this parameter
should be interpreted with the caution.
Conclusions
Sex and stroke location differ between VaMCI with MI
and those without MI. VaMCI with MI was more fre-
quently men and associated with infarcts on the left side
or within the basal ganglia or internal capsule. These dif-
ferences might be considered in the interpretation of
cognitive testing or rehabilitation of VaMCI patients.
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